Prescribing pattern of antihypertensive drugs in two European cohorts: a population-based database study

References

• World Health Organization. Global health risks. Mortality and burden of disease attributable to major risks; 2009. [cited 2018 Mar 2]. Available from: http://www.who.int/iris/handle/10665/44203
   Google Scholar
• Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963–975.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Bmj. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Borghi C, Tubach F, De Backer G, et al. Lack of control of hypertension in primary cardiovascular disease prevention in Europe: results from the EURIKA study. Int J Cardiol. 2016;218:83–88.
   PubMed Web of Science ®Google Scholar
• Schulz M, Krueger K, Schuessel K, et al. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients. Int J Cardiol. 2016;220:668–676.
   PubMed Web of Science ®Google Scholar
• Nicotra F, Wettermark B, Sturkenboom MC, et al. Management of antihypertensive drugs in three European countries. J Hypertens. 2009;27(9):1917–1922.
   PubMedGoogle Scholar
• World Health Organization. Improving health system efficiency as a means of moving towards universal coverage. World Health Report 2010. Background Paper, No 28; 2010. [cited 2018 Mar 30]. Available from: https://www.who.int/healthsystems/topics/financing/healthreport/28UCefficiency.pdf.
   Google Scholar
• Paalanen L, Koponen P, Laatikainen T, et al. Public health monitoring of hypertension, diabetes and elevated cholesterol: comparison of different data sources. Eur J Public Health. 2018;28(4):754–765.
   PubMed Web of Science ®Google Scholar
• Tocci G, Muiesan ML, Parati G, et al. Trends in prevalence, awareness, treatment, and control of blood pressure recorded from 2004 to 2014 during world hypertension day in Italy. J Clin Hypertens (Greenwich). 2016;18(6):551–556.
   PubMed Web of Science ®Google Scholar
• OECD & European Observatory on Health Systems and Policies. Country Health Profile 2017. State of health in the EU; 2017. [cited 2018 May 25]. Available from: https://ec.europa.eu/health/state/summary_en.
   Google Scholar
• Iolascon G, Gimigliano F, Moretti A, et al. Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database. Clin Cases Miner Bone Metab. 2016;13(2):127–130.
   PubMedGoogle Scholar
• Malo S, Bjerrum L, Feja C, et al. Compliance with recommendations on outpatient antibiotic prescribing for respiratory tract infections: the case of Spain. Basic Clin Pharmacol Toxicol. 2015;116(4):337–342.
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index; 2018. [cited 2018 Feb 27]. Available from: http://www.whocc.no/atc_ddd_index/
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.
   PubMed Web of Science ®Google Scholar
• Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%–a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol. 1998;54(2):113–118.
   PubMed Web of Science ®Google Scholar
• De Vito C, Massimi A, Di Thiene D, et al. Low level of attention to health inequalities in prevention planning activities of the Italian regions. Int J Equity Health. 2016;15:28.
   PubMed Web of Science ®Google Scholar
• Menendez E, Delgado E, Fernandez-Vega F, et al. Prevalence, diagnosis, treatment, and control of hypertension in Spain. Results of the [email protected] study. Rev Esp Cardiol (Engl Ed). 2016;69(6):572–578.
   PubMed Web of Science ®Google Scholar
• Giampaoli S, Palmieri L, Donfrancesco C, et al. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: osservatorio epidemiologico cardiovascolare/health examination survey 1998–2012. Eur J Prev Cardiol. 2015;22(2 Suppl):9–37.
   PubMedGoogle Scholar
• Banegas JR, Navarro-Vidal B, Ruilope LM, et al. Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment. Circ Cardiovasc Qual Outcomes. 2015;8(1):67–76.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–618.
   PubMed Web of Science ®Google Scholar
• Malo S, Aguilar-Palacio I, Feja C, et al. Persistence with statins in primary prevention of cardiovascular disease: findings from a cohort of Spanish workers. Rev Esp Cardiol (Engl Ed). 2018;71(1):26–32.
   PubMed Web of Science ®Google Scholar
• Menditto E, Cahir C, Aza-Pascual-Salcedo M, et al. Adherence to chronic medication in older populations: application of a common protocol among three european cohorts. Patient Prefer Adherence. 2018;12:1975-1987.
   PubMed Web of Science ®Google Scholar
• National Institute For Health and Care Excellence. Hypertension in adults: diagnosis and management; 2011. [cited 2018 May 3]. Available from: http://www.nice.org.uk/guidance/cg127
   Google Scholar
• Grupo de trabajo de hipertensión arterial de la Sociedad Española de Medicina de Familia y Comunitaria. Puntos de buena práctica en hipertension arterial; 2011. [cited 2018 May 25]. Available from: https://www.semfyc.es/formacion-y-recursos/puntos-de-buena-practica-clinica-en-hipertension-arterial/
   Google Scholar
• Menditto E, Orlando V, Malo-Fumanal S, Prados-Torres A, Cahir C. Measuring medication adherence in health-related databases. In: Costa E, editor. Adherence to Medical Plans for Active and Healthy Ageing. New York: Nova SciencePublisher; 2017. p. 189–206.
   Google Scholar
• Agencia Española de Medicamentos y Productos Sanitarios. Utilización de medicamentos antihipertensivos en España durante el periodo 2010–2017; 2018. [cited 2018 May 3]. Available from: http://www.aemps.gob.es/medicamentosUsoHumano/observatorio/informes.htm
   Google Scholar
• Sinnott SJ, Bennett K, Cahir C. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. Eur J Clin Pharmacol. 2017;73(11):1449–1455.
   PubMed Web of Science ®Google Scholar
• Menditto E, Orlando V, Malo-Fumanal S, et al. Measuring medication adherence in health-related databases. In: Costa E, editor. Adherence to Medical Plans for Active and Healthy Ageing. New York: Nova Science Publisher; 2017. p. 189-206.
   Google Scholar
• Lobo E, Rabanaque MJ, Carrera P, et al. Relationship between physician and industry in Aragon (Spain). Gac Sanit. 2012;26(4):336–342.
   PubMed Web of Science ®Google Scholar
• Fabbri A, Gregoraci G, Tedesco D, et al. Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies’ websites. BMJ Open. 2016;6(6):e011124.
   PubMed Web of Science ®Google Scholar